» Articles » PMID: 3395552

Modulation of Antifolate Cytotoxicity by Metabolites from Dying Cells in a Lymphocyte Clonal Assay

Overview
Journal Br J Cancer
Specialty Oncology
Date 1988 May 1
PMID 3395552
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A lymphocyte clonal assay developed to quantitate in vivo somatic cell mutations at the hypoxanthine-guanine phosphoribosyltransferase locus was modified in order to study resistance to methotrexate. Even though nucleoside-free culture conditions were used methotrexate was not lethal to lymphocytes plated into micro-wells at greater than 10(2) cells/well. HPLC analysis of supernatants from wells plated initially with 10(4) cells/well in 100 microM methotrexate revealed the presence of micro-molar levels of hypoxanthine and thymidine by the 5th and 8th day of culture respectively. When lymphocytes were plated at less than or equal to 10(2) cells/well in nucleoside free medium, methotrexate was cytotoxic and micro-molar levels of thymidine together with hypoxanthine protected lymphocytes cultured under these conditions from toxicity. Modulation of nucleic acid antimetabolite cytotoxicity by nucleosides and bases has been recognised for some years. Nucleoside free culture conditions have been advocated for studying cellular sensitivity to antifolates to avoid such interfering factors. However our results indicate that metabolites from dying or damaged cells can prevent methotrexate cytotoxicity, further complicating the development of a suitable clonogenic assay for investigating antifolate sensitivity.

Citing Articles

Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

Haber M, Madafiglio J, Norris M J Cancer Res Clin Oncol. 1993; 119(6):315-7.

PMID: 8449966 DOI: 10.1007/BF01208836.


Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.

Hughes J, Tattersall M Br J Cancer. 1989; 59(3):381-4.

PMID: 2930702 PMC: 2247054. DOI: 10.1038/bjc.1989.76.

References
1.
Saugstad O . Hypoxanthine as a measurement of hypoxia. Pediatr Res. 1975; 9(4):158-61. DOI: 10.1203/00006450-197504000-00002. View

2.
Cole J, Arlett C . Ethyl methanesulphonate mutagenesis with L5178Y mouse lymphoma cells: a comparison of ouabain, thioguanine and excess thymidine resistance. Mutat Res. 1976; 34(3):507-25. DOI: 10.1016/0027-5107(76)90226-8. View

3.
Howell S, Mansfield S, Taetle R . Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity. Cancer Res. 1981; 41(3):945-50. View

4.
TAYLOR I, Tattersall M . Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Cancer Res. 1981; 41(4):1549-58. View

5.
Agarwal R, Major P, Kufe D . Simple and rapid high-performance liquid chromatographic method for analysis of nucleosides in biological fluids. J Chromatogr. 1982; 231(2):418-24. DOI: 10.1016/s0378-4347(00)81866-6. View